Blog
IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…
Read MoreDr. Johann Gudjonsson discusses the mechanisms of paradoxical reactions and iatrogenic switches, framing them as immune…
Watch VideoWhat were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…
View ReportWhat were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…
Read MoreThe 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…
Read MoreThe 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…
Read MoreAt the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…
Read MoreExperts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…
View ReportExperts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…
Read MoreThe 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…
View ReportIPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…
Read MoreThe 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…
Read MoreDr. Johann Gudjonsson discusses how single-cell and spatial technologies are revolutionizing our understanding of the…
Watch VideoThe Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…
Read MoreThe 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…
Read MoreDr. Johann Gudjonsson discusses the key pathogenetic differences and similarities between psoriasis and atopic…
Watch VideoDr. Tiago Torres leads a panel of global experts in psoriasis and eczema as they discuss the first half of the…
Watch VideoThis report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…
Read MoreThe 53rd Annual European Society for Dermatological Research (ESDR) Meeting was held in Lisbon, Portugal, from…
View ReportGeneralized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View Report| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.